Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	9 Months Ended
	May 31, 2011	May 31, 2010
Cash flows from operating activities:
Net income	$ 267,417	$ 111,390
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	234,312	211,943
Recognition of deferred grant proceeds	(1,466)	(1,467)
Amortization of loss on hedge arrangement	2,963	2,963
Amortization of debt issuance costs and discount	3,990	2,770
Write-off of debt issuance costs	219
Recognition of stock-based compensation expense	59,854	67,980
Deferred income taxes	(2,305)	(8,230)
Restructuring and impairment charges	628	5,705
Provision for allowance for doubtful accounts and notes receivable	1,150	(222)
Excess tax benefit from options exercised	(178)	(118)
Loss on sale of property	3,061	4,607
Settlement of receivables and related charges	12,673
Loss on disposal of subsidiaries	23,944	12,756
Change in operating assets and liabilities, exclusive of net assets acquired:
Trade accounts receivable	100,226	(70,093)
Inventories	(187,146)	(607,742)
Prepaid expenses and other current assets	(145,384)	(126,005)
Other assets	(10,011)	1,556
Accounts payable and accrued expenses	148,289	509,838
Income taxes payable	12,181	24,545
Net cash provided by operating activities	524,417	142,176
Cash flows from investing activities:
Cash paid for business and intangible asset acquisitions, net of cash acquired	3,985
Acquisition of property, plant and equipment	(320,965)	(245,118)
Proceeds from sale of property, plant and equipment	13,669	7,257
Cost of receivables acquired, net of cash collections	(521)
Proceeds on disposal of available for sale investments	5,800
Net cash used in investing activities	(298,032)	(237,861)
Cash flows from financing activities:
Borrowings under debt agreements	5,706,610	3,703,460
Payments toward debt agreements	(5,714,853)	(3,812,960)
Net proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan	17,778	6,210
Treasury stock minimum tax withholding related to vesting of restricted stock	(9,739)	(5,487)
Dividends paid to stockholders	(45,306)	(44,901)
Bond issuance costs	(14,549)
Net proceeds from issuance of ordinary shares of certain subsidiaries		586
Bank overdraft of subsidiary		9,665
Excess tax benefit from options exercised	179	118
Net cash used in financing activities	(59,880)	(143,309)
Effect of exchange rate changes on cash and cash equivalents	311	(36,929)
Net increase (decrease) in cash and cash equivalents	166,816	(275,923)
Cash and cash equivalents at beginning of period	744,329	876,272
Cash and cash equivalents at end of period	$ 911,145	$ 600,349